Answers are grounded in this paper and cite their sources.
Breast cancer, a significant global health challenge, remains a leading cause of cancer-related morbidity and mortality worldwide, necessitating comprehensive strategies for diagnosis, treatment, and survivorship care. Early detection through modalities such as mammography, ultrasound, MRI, and tissue sampling is crucial. Genetic testing, on the other hand, identifies hereditary risks. Tissue sampling and biopsy provide a definitive histopathologic diagnosis. Breast cancer care aims to diagnose timely and achieve optimal outcomes while preserving quality of life. Surgical approaches remain integral to treatment, with options ranging from breast-conserving surgery (lumpectomy) to mastectomy based on tumor stage, size, and patient preference. Oncoplastic breast surgery combines oncologic resection with plastic surgical techniques to optimize esthetic outcomes without compromising cancer control. Breast reconstruction, using autologous tissue or implants, further enhances physical and psychological recovery. Surgical approaches often precede adjuvant therapies such as chemotherapy, radiation, and hormone therapy, which aim to reduce the risk of recurrence and improve survival rates. Prognosis varies based on factors such as tumor stage, grade, hormone-receptor status, and involvement of lymph nodes. Disparities in care exist based on factors such as socioeconomic status, race, and geographic location, affecting access to quality treatment and impacting prognosis. Ongoing research focuses on improving diagnostic accuracy, innovations in surgical techniques and systemic therapies, developing personalized therapies, and addressing healthcare inequities to improve outcomes for all women with breast cancer. This review highlights the importance of a holistic approach in optimizing outcomes and survivorship for patients with breast cancer.
No takes yet. Share an insight, caveat, or question.
Alsheikhly et al. (2025) studied this question.